Grown Rogue International (GRUSF) Cash from Operations Growth (1y) (2014 - 2026)
Grown Rogue International (GRUSF) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 240.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 240.30% |
| Mar 31, 2026 | 352.30% |
| Dec 31, 2025 | -15,247,565.85% |
| Jun 30, 2025 | -65.53% |
| Mar 31, 2025 | -200.89% |
| Jan 31, 2023 | 967.93% |
| Jan 31, 2022 | -51.30% |
| Oct 31, 2021 | 138,485,601.63% |
| Jul 31, 2021 | -90,013,223.15% |
| Apr 30, 2021 | -779.56% |
| Jan 31, 2021 | -17.94% |
| Oct 31, 2020 | -131.88% |
| Jul 31, 2020 | 81.86% |
| Apr 30, 2020 | 247.43% |
| Jan 31, 2020 | 106.93% |
| Oct 31, 2019 | -191.56% |
| Jul 31, 2019 | -85.76% |
| Apr 30, 2019 | 90.10% |
| Jan 31, 2019 | -135.42% |
| May 31, 2018 | 85.61% |